Carlos Buesa’s Post

https://lnkd.in/ex78H9gi Reagent-Controlled Divergent Synthesis of 2-Amino-1,3-Benzoxazines and 2-Amino-1,3-Benzothiazines

https://lnkd.in/eddFHWBq Reagent-Controlled Divergent Synthesis of 2-Amino-1,3-Benzoxazines and 2-Amino-1,3-Benzothiazines

Open-label, multi-center Phase 1/2 study (BRUIN) Relapse/Refractory CLL/SLL who had previously received a BTK inhibitor Pirtobrutinib (n=317) https://lnkd.in/eY6Ebx44

It is critical that manufacturers are well equipped to deal with the potential obstacles and challenges they will face as they bring new products to the world’s two largest pharmaceutical markets with the implementation of the Inflation Reduction Act (IRA) in the United States and Joint Clinical Assessments (JCA) in the European Union. Join us during our upcoming webinar as we compare and contrast these two seismic changes to the value and access landscape and provide some best practices and experience-based key learnings to help manufacturers to prepare for the implications of these changes. Learn more and register at https://buff.ly/3TGkfnd #inflationreductionact #IRA #EUHTAregulation #EUHTA #JCA #HEOR #jointclinicalassessments #valueandaccess

It is critical that manufacturers are well equipped to deal with the potential obstacles and challenges they will face as they bring new products to the world’s two largest pharmaceutical markets with the implementation of the Inflation Reduction Act (IRA) in the United States and Joint Clinical Assessments (JCA) in the European Union. Join us during our upcoming webinar as we compare and contrast these two seismic changes to the value and access landscape and provide some best practices and experience-based key learnings to help manufacturers to prepare for the implications of these changes. Learn more and register at https://buff.ly/3U0E5ev #inflationreductionact #IRA #EUHTAregulation #EUHTA #JCA #HEOR #jointclinicalassessments #valueandaccess

basic information and involvement of ribonucleotide in regulation 1.cAMP 2.cGMP

Learn our tips and tricks to avoiding the nasty side effects of using a GLP-1 like #ozempic or #wegovy https://bit.ly/3MECqqr #BagTheSag #Semaglutide #glp1

This discussion of Critical Limb Ischemia shares insight on historical treatment approaches, the evolution of minimally-invasive interventions over the years, and the importance of a comprehensive approach to limb salvage. https://lnkd.in/eyvCebhv Terry Roberts #cardiovascularmatters

#Nitrosamines ... I have been MIA for a bit, but all for good reasons! The Nitrosamines Exchange Community is soon to have some exciting initiatives and resources! One of those related to Risk Assessment 👈 🤫 In the meantime, 👀 Are you keeping up with the progress on the ICH M7 sub-group forming to update the guideline to include Nitrosamines and NDSRIs? 👀 Did you see the most recent update on EMA Acceptable Intake limits for NDSRIs? 👀 Did you read the recent publication by regulators on how CPCA was created and deployed? You want to make sure you get everything happening in the Nitrosamines Jumanji! Come join USP's Nitrosamines Exchange Community, the only knowledge-based community for all things Nitrosamines. #nitrosaminas #nitrosammine #nitrosaminne #nitrosamine

Learn our tips and tricks to avoiding the nasty side effects of using a GLP-1 like #ozempic or #wegovy https://bit.ly/3MECqqr #BagTheSag #Semaglutide #glp1